CHE EBITDA Growth
Chemed Corp · EBITDA Growth
CHE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-4.79%period ending
CHE TTM EBITDA YoY % (68.45% → -4.79%)
Year-over-year change
High-resolution chart · PNG
CHE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -4.7918% | |
| -12.0855% | |
| -8.6973% | |
| -4.6254% | |
| 0.4862% | |
| 11.2393% | |
| 12.0563% | |
| 20.405% | |
| 23.6969% | |
| 12.2803% | |
| 5.3135% | |
| -6.0675% | |
| -13.9731% | |
| -7.8949% | |
| -4.3949% | |
| -11.8611% | |
| -4.9617% | |
| -11.8526% | |
| -9.4573% | |
| 18.513% | |
| 20.0878% | |
| 40.8564% | |
| 45.9793% | |
| 33.7734% | |
| 30.0122% | |
| 19.3941% | |
| 9.8415% | |
| 4.71% | |
| 6.6258% | |
| 63.4083% | |
| 80.7575% | |
| 84.3622% | |
| 92.0026% | |
| -21.8121% | |
| -27.2011% | |
| -28.5115% | |
| -34.5768% | |
| 0.8334% | |
| -0.1738% | |
| -3.2561% | |
| 1.2278% | |
| 4.2163% | |
| 5.7242% | |
| 10.8947% | |
| 14.2577% | |
| 22.2801% | |
| 18.7361% | |
| 11.7094% | |
| 0.4678% | |
| -12.3053% | |
| -9.5885% | |
| -6.6346% | |
| -3.2789% | |
| 2.9508% | |
| 3.3597% | |
| 5.5054% | |
| 7.7934% | |
| 8.4974% | |
| 5.2107% | |
| 7.2714% | |
| 7.8993% | |
| 8.2949% | |
| 9.1881% | |
| 2.2605% | |
| 0.0018% | |
| -0.6471% | |
| 3.034% | |
| 6.1052% | |
| 9.9313% | |
| 8.0608% | |
| 4.0695% | |
| 1.6974% | |
| 4.2199% | |
| 8.4693% | |
| 13.3126% | |
| 40.1685% | |
| 31.0906% | |
| 31.6836% | |
| 28.2966% | |
| -3.2947% | |
| 2.316% | |
| -0.83% | |
| 26.0279% | |
| 86.7473% | |
| 166.9557% | |
| 431.9911% | |
| 320.7361% | |
| 159.7626% | |
| 51.0592% | |
| -31.6257% | |
| -40.894% | |
| -35.5393% | |
| -15.1609% | |
| -14.8738% | |
| -17.2244% | |
| -20.8605% | |
| -42.7874% | |
| -40.4041% | |
| -30.4375% | |
| -17.3209% |